-
Loading metrics
Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights
-
Amanda Watson ,
Contributed equally to this work with: Amanda Watson, Pankil Shah
Roles Formal analysis, Investigation
Affiliation Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America
⨯ - Pankil Shah ,
- Doug Lee,
- Sitai Liang,
-
Geeta Joshi,
Roles Formal analysis, Writing – review & editing
Affiliation Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America
⨯ -
Ediri Metitiri,
Roles Writing – review & editing
Affiliation Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America
⨯ -
Wasim H. Chowdhury,
Roles Formal analysis
Affiliation Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America
⨯ - Dean Bacich,
- Peter Dube,
- Yan Xiang,
- Daniel Hanley,
- Luis Martinez-Sobrido,
-
Ronald Rodriguez
Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing
* E-mail: Rodriguezr32@uthscsa.edu
Affiliation Department of Medical Education, and Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America
⨯
https://orcid.org/0000-0001-6893-1926
Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights
- Amanda Watson,
- Pankil Shah,
- Doug Lee,
- Sitai Liang,
- Geeta Joshi,
- Ediri Metitiri,
- Wasim H. Chowdhury,
- Dean Bacich,
- Peter Dube,
- Yan Xiang
- Published: August 2, 2024
- https://doi.org/10.1371/journal.pone.0307154